Butterbur (Petasites).
The most effective natural migraine preventer Provides standardized petasins for reliable migraine prevention
Reviewed March 2026
- Category
- Herb
- Also filed under
- Migraine PreventionAllergiesAnti Inflammatory
What Butterbur (Petasites) is, and what it does.
- Does it work
- Standardization ensures consistent results. Well-researched for migraines.
- How much to take
- Start with 50 to 75mg a day of extract standardised to petasin and isopetasin, split across two doses with food. That is the daily maintenance band.
- Time to feel it
- Three to four months of daily use is the window the trials measured across. In week one the change is counted in a diary rather than registered as a sensation.
- The first dose
- Nothing registers on day one. The esters are absorbed along with the fat in your meal, and the outcome studied here is counted across months in a diary.
- With regular use
- Across three to four months of daily use, trials counted monthly head comfort and seasonal nasal comfort. The change reads as a tally over time rather than a single day.
- How well tolerated
- Well tolerated if PA-free. Standardization ensures quality.
- How it feels
- It isn't something you feel arriving. What people describe is easier breathing through pollen months and fewer disrupted days across a season, usually noticed in hindsight.
- The overlooked benefit
- Petasin flips into isopetasin under heat and acid, so a label naming both isomers tells you more about how the batch was handled than one naming petasin alone.
50 to 150mg a day is where Butterbur (Petasites) works.
Source: AAN 2012 Guideline Update: Level A evidence. Lipton et al. 2004 Neurology RCT.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Butterbur (Petasites) has emerging evidence. Based on 97+ studies.
- monthly frequency of head discomfort in adultsRandomised trial
- nasal and eye comfort through high pollen monthsRandomised trial
- calcium channel modulation in smooth muscleIn vitro study
- leukotriene formation in leukocyte preparationsIn vitro study
Questions people ask about Butterbur (Petasites).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Riboflavin supports mitochondrial electron transport through FAD, a metabolic route entirely separate from petasin's action on calcium channels and leukotriene synthesis. The two are the standard partners in neurological comfort formulas.
Magnesium acts as a natural counter-ion at NMDA and voltage-gated calcium channels, and petasin also damps calcium entry in smooth muscle. Both reduce excess calcium flux by different routes and are routinely combined.
CoQ10 carries electrons in the respiratory chain and supports cellular energy status, which is a different lever from butterbur's action on vascular smooth muscle. The pair is standard in the same category of formulas.
Quercetin stabilises mast cells and limits histamine release, while petasin damps the leukotriene arm downstream. Two different mediator pathways of the same response are covered.
Nettle leaf constituents interact with the histamine H1 receptor and mast cell tryptase, whereas petasin acts on leukotriene synthesis. Seasonal formulas pair them for that non-overlap.
Ascorbate acts as a cofactor in the enzymatic breakdown of histamine, a clearance step, while petasin acts on the leukotriene arm of the same response. Production and removal are addressed separately.
Parthenolide from feverfew and petasin from butterbur both dampen inflammatory lipid mediator production, though at different points in the cascade. The two appear together in traditional and commercial formulas far more often than they have been tested together. Any additive effect is inferred from their separate mechanisms rather than measured in a combination trial. The pairing supports normal comfort in the head and neck region without either ingredient being characterised as acting on a condition.
Petasin and isopetasin reduce leukotriene formation, while gingerols act largely on prostaglandin synthesis, so the two cover complementary arms of arachidonic acid metabolism. Ginger also settles gastric tone, which matters because butterbur extracts are commonly taken with food. The combination has not been tested head to head in people. Read it as mechanistic complementarity rather than a measured additive result.
Butterbur sesquiterpenes reduce leukotriene output, and boswellic acids do so by binding 5-lipoxygenase directly. Two agents converging on the same branch can be additive, and can also make it hard to attribute any effect to either one. The pairing appears in joint and airway comfort formulas without a combination trial behind it. It supports normal inflammatory balance rather than acting on any named condition.
Long chain omega-3 fatty acids displace arachidonic acid from membrane phospholipids, so the substrate reaching 5-lipoxygenase changes as well as the enzyme's activity. Petasin works on the enzyme side of that same junction. Substrate competition and enzyme modulation together are a coherent pairing, and the substrate half is well established biochemistry. The combined effect in people has not been quantified.
L-theanine raises alpha wave activity and modulates glutamatergic tone, a different mechanism entirely from petasin's effects on smooth muscle and eicosanoids. The pairing is a formulation choice rather than a documented interaction. Nothing suggests either changes the other's absorption or metabolism. It belongs on the page as formulation context.
Melatonin acts through MT1 and MT2 receptors on vascular smooth muscle, while petasin behaves like a calcium channel modulator in the same tissue. The overlap is anatomical rather than molecular. No combination study has measured them together. Anyone stacking sedating ingredients should count the total, since additive drowsiness is the plausible practical consequence.
Unrefined butterbur carries pyrrolizidine alkaloids, which is precisely why alkaloid-depleted extracts exist as a separate form. Silymarin supports normal hepatic antioxidant status and is a conventional companion where a botanical carries any hepatic load. The pairing is precautionary formulation logic, not a tested combination. The more important point is that the alkaloid content is a property of the raw material and processing, not something a companion ingredient corrects.
Hyperforin is one of the strongest botanical inducers of CYP3A4 and intestinal efflux transport, and that induction is established pharmacology rather than a hypothesis. Petasin and isopetasin are lipophilic esters that plausibly move through those same routes. The practical consequence is lower exposure to the butterbur constituents when the two are taken together. This is a direction of effect, not a measured magnitude.
Piperine's inhibition of intestinal and hepatic phase one and phase two metabolism is well characterised and is why it appears in so many extract formulas. For a botanical whose alkaloid content is the main reason for careful processing, raising systemic exposure is a consideration in both directions rather than a straightforward benefit. No study has measured piperine with butterbur specifically. The pairing deserves a caveat rather than a recommendation.
Petasin acts on mediator production directly, while curcumin acts a step earlier at the transcriptional level that sets how much enzyme is present. Working at two levels of the same pathway is a reasonable formulation rationale. Curcumin's own absorption is poor without a lipid or piperine vehicle, which complicates any joint interpretation. No combination data exist for the pair.
Bromelain modulates bradykinin and prostaglandin production and is used to thin mucosal secretions, a different lever from petasin's smooth muscle and leukotriene effects. The combination is a long-standing formulation convention in the naturopathic literature. It has not been tested as a pair in controlled work. It supports normal upper airway comfort without either component acting on a named condition.
Concentrated green tea catechin extracts and unrefined butterbur have each been associated with hepatic enzyme changes in case reports, at extract concentrations far above culinary intake. Stacking two concentrated botanicals raises the combined burden even where neither is individually remarkable. This is an additive caution, not a synergy anyone should seek. Alkaloid-depleted butterbur forms exist specifically because the raw material carries this consideration.
Nothing specific on file for Butterbur (Petasites). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Butterbur (Petasites) actually does.
The characteristic actives are petasin and isopetasin, sesquiterpene esters of petasol with angelic acid, and their proportions differ between chemotypes of Petasites hybridus.
The raw root of Petasites hybridus contains hepatotoxic pyrrolizidine alkaloids, which is why commercial extracts are processed by carbon dioxide or solvent methods designed to remove them and are specified with an alkaloid limit.
Petasin and isopetasin are lipophilic esters, so extraction efficiency and the choice of extraction solvent determine which sesquiterpene profile ends up in the finished extract.
Petasin behaves as a calcium channel modulator in vascular and bronchial smooth muscle, which is the basis of the relaxation described in isolated tissue preparations.
Where Butterbur (Petasites) comes from.
It starts as the root of a European wetland plant. The useful oily compounds are pulled out with carbon dioxide or alcohol, a separate step strips out the alkaloids the raw root naturally carries, and the finished extract is tested so the label figure means something.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Butterbur is a wetland perennial harvested for its rhizome and root, mainly from cultivated plots in central Europe where chemotype and growing site both influence the petasin to isopetasin ratio.
The dried, milled root is extracted either with supercritical carbon dioxide, which favours the lipophilic sesquiterpene esters, or with ethanol or acetone, which pulls a broader profile that then needs a separate clean-up.
Because the raw root carries hepatotoxic pyrrolizidine alkaloids, commercial material passes an ion exchange, adsorption or partition step aimed at the alkaloid fraction, with the residual level tested and stated.
The extract is assayed by high performance liquid chromatography and adjusted to a declared combined petasin plus isopetasin percentage, with a parallel alkaloid limit on the same certificate.
The lipophilic extract is either filled directly into softgels or adsorbed onto a carrier such as maltodextrin or silica to produce a free-flowing powder for capsules and tablets.
Getting Butterbur (Petasites) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In 20 grass-pollen-sensitised adults, two weeks of butterbur extract 50 mg twice daily blunted the fall in peak nasal inspiratory flow after an adenosine monophosphate nasal challenge to about 30 percent versus 43 percent on placebo.Randomised trial. Lee et al., 2003 (Clinical and Experimental Allergy). PMID 12859442 ↗
These are the studies our verdict leans on, chosen from the 356 we read for Butterbur (Petasites). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.